[go: up one dir, main page]

MXPA04005839A - Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen. - Google Patents

Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen.

Info

Publication number
MXPA04005839A
MXPA04005839A MXPA04005839A MXPA04005839A MXPA04005839A MX PA04005839 A MXPA04005839 A MX PA04005839A MX PA04005839 A MXPA04005839 A MX PA04005839A MX PA04005839 A MXPA04005839 A MX PA04005839A MX PA04005839 A MXPA04005839 A MX PA04005839A
Authority
MX
Mexico
Prior art keywords
same
pharmaceutical compositions
compositions containing
benzothiadiazine derivatives
represents hydrogen
Prior art date
Application number
MXPA04005839A
Other languages
English (en)
Inventor
Lestage Pierre
Original Assignee
Servier Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab filed Critical Servier Lab
Publication of MXPA04005839A publication Critical patent/MXPA04005839A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Se describen los compuestos de la Formula (I):(ver formula I)En donde:R1 representa un arilo o heteroarilo,R2 representa un hidrogeno, halogeno o un hidroxilo,X representa un oxigeno o azufre,Y representa un oxigeno, azufre, o NR, en donde R representa un hidrogeno o un alquilo,A representa CR4R5 o NR4,R3 representa un hidrogeno, alquilo o cicloalquiloR4 representa un hidrogeno o alquilo,oA representa un nitrogeno y, junto con el grupo -CHR3adyacente, forma el anillo (ver formula) en donde m representa1,2 o 3,R5 representa un hidrogeno o halogeno,Sus isomeros y sus sales de adicion.Dichos compuestos son utiles como medicinas, como moduladores de AMPA.
MXPA04005839A 2001-12-21 2002-12-20 Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen. MXPA04005839A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0116620A FR2833955B1 (fr) 2001-12-21 2001-12-21 Nouveaux derives de benzothiazine et de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/FR2002/004483 WO2003053978A1 (fr) 2001-12-21 2002-12-20 Nouveaux derives de benzothiazine et benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (1)

Publication Number Publication Date
MXPA04005839A true MXPA04005839A (es) 2004-09-10

Family

ID=8870808

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04005839A MXPA04005839A (es) 2001-12-21 2002-12-20 Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen.

Country Status (21)

Country Link
US (1) US7262189B2 (es)
EP (1) EP1472219A1 (es)
JP (1) JP2005518385A (es)
KR (1) KR100586684B1 (es)
CN (1) CN1289508C (es)
AR (1) AR038260A1 (es)
AU (1) AU2002364673B2 (es)
BR (1) BR0214926A (es)
CA (1) CA2471120A1 (es)
EA (1) EA007492B1 (es)
FR (1) FR2833955B1 (es)
GE (1) GEP20063757B (es)
HU (1) HUP0402583A3 (es)
MA (1) MA27088A1 (es)
MX (1) MXPA04005839A (es)
NO (1) NO20042708L (es)
NZ (1) NZ533329A (es)
PL (1) PL370166A1 (es)
UA (1) UA78742C2 (es)
WO (1) WO2003053978A1 (es)
ZA (1) ZA200404295B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2877342B1 (fr) * 2004-11-03 2007-01-26 Servier Lab Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
KR101852215B1 (ko) 2010-08-10 2018-04-25 다케다 야쿠힌 고교 가부시키가이샤 헤테로시클릭 화합물 및 이의 용도
TWI873185B (zh) 2019-09-16 2025-02-21 日商武田藥品工業股份有限公司 唑稠合之嗒-3(2h)-酮衍生物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722502B1 (fr) * 1994-07-12 1996-08-23 Adir Nouveau derive de benzothiadiazine, son procede depreparation et les compositions pharmaceutiques qui le contiennent
RU2214405C2 (ru) * 1998-02-18 2003-10-20 НьюроСёрч А/С Новые соединения и их применение в качестве положительных модуляторов амра-рецепторов
FR2812291B1 (fr) * 2000-07-28 2002-12-13 Adir Nouveaux derives de benzothiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
EA007492B1 (ru) 2006-10-27
ZA200404295B (en) 2005-06-01
KR20040073479A (ko) 2004-08-19
KR100586684B1 (ko) 2006-06-08
HUP0402583A2 (hu) 2005-03-29
HK1071746A1 (en) 2005-07-29
NO20042708L (no) 2004-06-28
PL370166A1 (en) 2005-05-16
NZ533329A (en) 2006-10-27
MA27088A1 (fr) 2004-12-20
US20050065146A1 (en) 2005-03-24
AU2002364673A1 (en) 2003-07-09
JP2005518385A (ja) 2005-06-23
CA2471120A1 (fr) 2003-07-03
AR038260A1 (es) 2005-01-12
FR2833955A1 (fr) 2003-06-27
AU2002364673B2 (en) 2007-11-22
US7262189B2 (en) 2007-08-28
BR0214926A (pt) 2004-11-30
HUP0402583A3 (en) 2009-01-28
WO2003053978A1 (fr) 2003-07-03
GEP20063757B (en) 2006-02-27
EA200400757A1 (ru) 2004-10-28
UA78742C2 (en) 2007-04-25
CN1289508C (zh) 2006-12-13
EP1472219A1 (fr) 2004-11-03
CN1606559A (zh) 2005-04-13
FR2833955B1 (fr) 2004-01-30

Similar Documents

Publication Publication Date Title
DE60315265D1 (de) Stickstoffhaltige heterocyclische verbindung und arzneimittel davon
IL160304A (en) Compounds and composition for activating peroxisome proliferators-responsive receptor ??
WO2002059102A3 (fr) Derives de l'uree, leur procede de preparation, leur application a titre de medicaments, compositions pharmaceutiques et utilisation
DE69820248D1 (de) Pyrrolidin-derivate die eine phospholipase-a2-hemmende wirkung haben
TW368501B (en) 7-(2-aminoethyl)-benzothiazolones
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
MXPA04005837A (es) Nuevos derivados de benzotiazina y benzotiadiazina, metodo para su preparacion y composiciones farmaceuticas que los contienen.
ATE240949T1 (de) Epoxysuccinamid-derivate oder ihre salze
MXPA04005839A (es) Nuevos compuestos de benzotiazina y benzotiadiazina un proceso para su preparacion y las composiciones farmaceuticas que los contienen.
UA50722C2 (uk) Нітробензаміди, спосіб їх одержання (варіанти), фармацевтична композиція
ATE277075T1 (de) Tripeptidische verbindungen mit wirksamkeit als selektive inhibitoren der aminopeptidase a und sie enthaltende pharmazeutische zusammensetzungen
SG148023A1 (en) New benzothiazine and benzothiadiazine compounds, a process for their preparation and pharmaceutical compositions containing them
PL359460A1 (en) Carbamate and thiocarbamate podophyllotoxin derivatives, preparation method and pharmaceutical compositions containing them
EA200400667A3 (ru) Новые соединения бензотиазина и бензотиадиазина, способ их получения и фармацевтические композиции, которые их содержат
EP1197211A4 (en) CANCER PREVENTION AND TREATMENT ACTIVE INGREDIENTS
DK0410224T3 (da) Pyrrolo(2,1-b)thiazol-derivater
AU2002214266A1 (en) Carbamate derivatives, process for producing the same and use thereof
EP1466900A4 (en) DERIVATIVES OF VITAMIN D-DOUBLE SUBSTITUTION
DK1097145T3 (da) Polyhydroxyalkylpyrazinderivater, deres fremstilling og lægemidler indeholdende disse derivater
DE69904940D1 (de) 6-deoxy-erythromycin-derivate, ihrer herstellung, und ihrer verwendung als arzneimitteln

Legal Events

Date Code Title Description
FG Grant or registration